Sequential and Concurrent FOLFOXIRI/Bevacizumab Regimens Versus FOLFOX/Bevacizumab in First-Line Metastatic Colorectal Cancer
Clinical trial NCT01765582 · TERMINATED
Trial details
- NCT number
- NCT01765582
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-23
- Primary completion
- 2016-03-14
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.